A new study by Johns Hopkins Bloomberg School of Public Health researchers found that U.S.-based patient advocacy organizations received a disproportionate amount of contributions made by the world's 10 largest pharmaceutical companies in 2016.
source https://www.lifetechnology.com/blogs/life-technology-news-blog/us-patient-advocacy-groups-received-majority-of-pharma-donations-in-multi-country-study